(Q46690587)

English

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

0 references

Stéphane Terry

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

author name string

Guillaume Ploussard

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Alexandre de la Taille

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Yves Allory

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Idir Ouzaïd

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Francis Vacherot

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Claude-Clément Abbou

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Laurent Salomon

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

publication date

31 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

31

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

1060-1066

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Active surveillance for prostate cancer: for whom?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Predictors of histological disease progression in untreated, localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Contemporary trends in low risk prostate cancer: risk assessment and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

The role of biopsy core number in selecting prostate cancer patients for active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Comparison of cancers detected at only a sextant or alternative location

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Detailed mapping of prostate carcinoma foci: biopsy strategy implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.018

7 January 2021

Identifiers

10.1016/J.UROLONC.2011.12.018

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/22300755

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46690587&oldid=2126861369"